SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63389 357 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
61132SAVA : SEC clearing them from investigation officially ....[graphic]plhky346589/20/2022
61131Lupkynis approved in Europe, pending in Britain and Switzerland. 30 million miledrtom123489/19/2022
61130Wow! Tragic yet Powerful. Thank you for sharing.Davidoff-9/18/2022
61129OT I mentioned a girl that I know, went through a horrific event on the Oregon idahoranch169/18/2022
61128BLUE- 2 FOR 2. Last month the FDA approved Bluebird's first product. Yestersummer_sky-9/17/2022
61127Sorry, just had past 3 days. All three were 24%-24.47%. Rates change dependingDavidoff-9/16/2022
61126Also, how often are those shares returned? For me it happens maybe 2-3 times perghettogoulash-9/16/2022
61125Davidoff, do you know how that interest rate has fared over the past two weeks? ghettogoulash-9/16/2022
61124Never mind. I see that Davidoff anticipated my question and answered it. Thankjargonweary-9/16/2022
61123So the 20% interest payment to you is applied to what valuation?jargonweary-9/16/2022
61122Yes, you can loan your stock to shorts and it very easy to turn off, or in the cDavidoff-9/16/2022
61121Schwab sent me an e-mail yesterday asking to set up loaning the SAVA shares fromerickerickson-9/16/2022
61120Schwab loan rate on SAVA now 20.5 %.sysiphus-9/16/2022
61119At $4.20 in June, I said the stock would probably double upon FDA acceptance of ghettogoulash19/15/2022
61118wild swing in price on 4X volume in IBRX...can't find anything on the net??urslor-9/15/2022
61117That's an easy one. Just look at the rest of the market. It has so much compOlecranon-9/14/2022
61116A better question is what was it doing at $2-3?ghettogoulash-9/14/2022
61115IBRX has been a tear the last several days on no obvious news. Any ideas why?Olecranon19/14/2022
61114Remi B. had an interesting comment at the end of the HC Wainwright conference yeghettogoulash-9/14/2022
61113IBRX finally hit my cost average today, after a lot of averaging down. But I nevghettogoulash-9/14/2022
61112Sarepta Therapeutics Announces Proposed Offering of $1.0 Billion of Convertible erickerickson19/12/2022
61111At a cursory glance, that blood test looks very promising, but it has nothing toghettogoulash-9/11/2022
61110SavaDX....Remi don't worry about it !! Just like when Zevalin was approved scorman1-9/10/2022
61109Hope Everyone is Doing Well. Been Awhile. Anyone have any opinions on NAUT? Lgonnahappensoon-9/9/2022
61108SAVA loan now 19% from Schwab and stock pps up $3.19. This is fun.sysiphus19/9/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News